Topically applied physiologically balanced growth factors: A new paradigm of skin rejuvenation

Journal of Drugs in Dermatology

Volumn 8, Issue 5, 2009, Pages 4-13

  Sundaram, Hema ^a,b   Mehta, Rahul C ^c   Norine, Josie A ^c   Kircik, Leon ^d,e   Cook Bolden, Fran E ^f,g   Atkin, Deborah H ^h   Werschler, W Philip ⁱ   Fitzpatrick, Richard E ^j  

^a Dermatology Cosmetic and Laser Surgery   (United States)

^b Dermatology Cosmetic and Laser Surgery   (United States)

^c SkinMedica Inc   (United States)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DermResearch PLLC   (United States)

^f Skin Specialty Group ^*  (United States)

^g Skin Specialty Group   (United States)

^h Dermatology and Laser of del Mar   (United States)

ⁱ UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^j La Jolla Cosmetic Surgery Centre   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LEPTIN; NOURICEL MD; NOURICELL MD; OSTEOGENIC PROTEIN 1; PLACENTAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SOMATOMEDIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TNS RECOVERY COMPLEX; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; SIGNAL PEPTIDE;

AGING; ARTICLE; CELL ACTIVITY; CELL COUNT; CELL MIGRATION; CLINICAL TRIAL (TOPIC); CREAM; CUTANEOUS PARAMETERS; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG MECHANISM; DRUG PENETRATION; DRUG POTENTIATION; DRUG SYNTHESIS; EPIDERMIS; GEL; HUMAN; KERATINOCYTE; MOLECULAR WEIGHT; NONHUMAN; SHELF LIFE; SKIN DEFECT; SKIN FIBROBLAST; SKIN FUNCTION; SKIN REJUVENATION; SKIN STRUCTURE; SKINFOLD THICKNESS; TISSUE REPAIR; WRINKLE; DRUG COMBINATION; DRUG EFFECT; PATHOLOGY; PHYSIOLOGY; REJUVENATION; REVIEW; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; DRUG COMBINATIONS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; REJUVENATION; SKIN AGING;

EID: 67650306176     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Werner S, Krieg T, Smola H. Keratinocyte-fibroblast interaction in wound healing. J Invest Dermatol. 2007;127(5):998-1008.
2. Babu M and Wells A. Dermal-epidermal communications in wound healing. Wounds. 2001;13:183-189.
3. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: Molecular and cellular mechanisms. J Invest Dermatol. 2007;127(3):514-525
4. Gilchrest BA. Skin aging and photoaging: An overview. J Am Acad Dermatol. 1989;(3 Pt 2)21:610-613. (Pubitemid 19211184)
5. Farage MA, Miller KW, Elsner P, et al. Intrinsic and extrinsic factors in skin ageing: A review. Int J Cosmet Sci. 2008(2);30:87-95. (Pubitemid 351392879)
6. Oikarinen A. The aging of skin: Chronoaging versus photoaging. Photodermatol Photoimmunol Photomed. 1990;7(1):3-4. (Pubitemid 20307473)
7. Baumann L. Skin ageing and its treatment. J Pathol. 2007;211(2):241-251. (Pubitemid 46195522)
8. Fisher GJ, Wang ZQ, Datta SC, et al. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med. 1997;337(20):1419-1428. (Pubitemid 27497889)
9. Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science. 1996;273(5271):59-63. (Pubitemid 26255420)
10. Cobb MH. MAP kinase pathways. Prog Biophys Mol Biol. 1999;71(3-4):479- 500. (Pubitemid 29156313)
11. Schwartz E, Cruickshank FA, Christensen CC, et al. Collagen alterations in chronically sun-damaged human skin. Photochem Photobiol. 1993;58(6):841-844. (Pubitemid 2030488)
12. Rossert J, Terraz C, Dupont S. Regulation of type I collagen genes expression. Nephrol Dial Transplant. 2000;15 Suppl 6:66-8.
13. Fu X, Parks WC, Heinecke JW. Activation and silencing of matrix metalloproteinases. Semin Cell Dev Biol. 2008;19(1):2-13. (Pubitemid 350235984)
14. Sur I, Ulvmar M, Toftgård R. The two-faced NF-kappaB in the skin. Int Rev Immunol. 2008;27(4):205-223.
15. Mehta RC, Smith SR, Grove GL, et al. Reduction in facial photodamage by a topical growth factor product. J Drugs Dermatol . 2008;7(9):864-871.
16. Eriksson A, Siegbahn A, Westermark B, et al. PDGF alpha-and beta-receptors activate unique and common signal transduction pathways. EMBO J. 1992;11(2):543-550.
17. Madlener FA and Werner S. Transforming growth factors beta1, beta 2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem. 1996;271:10188-10193. (Pubitemid 26131583)
18. Werner S, Peters KG, Longaker MT, et al. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci USA. 1992;89(15):6896-6900.
19. Williams MJ, Clark P. Microscopic analysis of the cellular events during scatter factor/hepatocyte growth factor-induced epithelial tubulogenesis. J Anat. 2003;203(5):483-503. (Pubitemid 37441578)
20. Mueller RV, Hunt TK, Tokunaga A, Spencer EM. The effect of insulinlike growth factor I on wound healing variables and macrophages in rats. Arch Surg. 1994;129(3):262-265. (Pubitemid 24103316)
21. Failla CM, Odorisio T, Cianfarani F, et al. Placenta growth factor is induced in human keratinocytes during wound healing. J Invest Dermatol. 2000;115(3):388-395.
22. Ferrara N, Houck KA, Jakeman LB, et al. The vascular endothelial growth factor family of polypeptides. J Cellular Biochem. 1991;47(3):211-218.
23. Brenneisen P,Wenk J, Klotz LO et al. Central role of ferrous/ferric iron in the ultraviolet B irradiation-mediated signaling pathway leading to increased interstitial collagenase (matrix-degrading metalloprotease (MMP) -1) and stromelysin-1 (MMP-3) mRNA levels in cultured human dermal fibroblasts. J Biol Chem. 1998;273(9):279-5287.
24. Bertaux B, Hornebeck W, Eisen AZ, Dubertret. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol. 1991;97(4):679-685.
25. Mori Y, Hatamochi A, Arakawa M, Ueki H. Reduced expression of mRNA for transforming growth factor beta (TGF beta) and TGF beta receptors I and II and decreased TGF beta binding to the receptors in in vitro-aged fibroblasts. Arch Dermatol Res.1998;290(3):158-162. (Pubitemid 28143369)
26. Canalis E. Skeletal growth factors and aging. J Clin Endocrinol Metabol. 1994;78(5):1009-1010
27. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165-169. (Pubitemid 30255378)
28. Jakasa I, Verberk MM, Esposito M, et al. Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. J Invest Dermatol. 2007;127(1):129-134. (Pubitemid 46005670)
29. Fitzpatrick RE and Rostan EF. Reversal of photodamage with topical growth factors: A pilot study. J Cosmet Laser Ther. 2003:5(1):25-34. (Pubitemid 36626779)
30. Gold MH, Goldman MP, Biron J. Human growth factor and cytokine skin cream for facial skin rejuvenation as assessed by 3D in vivo optical skin imaging. J Drugs Dermatol. 2007;6(10):1018-1023.
31. Mehta RC, Fitzpatrick RE. Endogenous growth factors as cosmeceuticals. Dermatol Ther. 2007;20(5):350-359.
32. Vogt A, Hadam S, Heiderhoff M, et al. Morphometry of human terminal and vellus hair follicles. Exp Dermatol. 2007;16(11):946-950. (Pubitemid 47570635)
33. Ciotti SN, Weiner N. Follicular liposomal delivery systems. J Liposome Res. 2002;12(1-2):143-148. (Pubitemid 34846966)
34. Lademann J, Otberg N, Jacobi U, et al. Follicular penetration and targeting. J Invest Dermatol Symp Proc. 2005:10(3):301-303.
35. Baroli B, Ennas MG, Loffredo F et al. Penetration of metallic nanopartiles in human full-thickness skin. J Invest Derm. 2007;127(7):1701-1712. (Pubitemid 46933398)
36. Skountzou I, Quan FS, Jacob J, et al. Transcutaneous immunization with inactivated influenza virus induces protective immune responses. Vaccine. 2006;24(35-36):6110-6119. (Pubitemid 44175614)
37. Jakasa I, Verberk MM, Bunge AL, et al. Increased permeability for polyethylene glycols through skin compromised by sodium lauryl sulphate. Exp Dermatol. 2006;15(10):801-807. (Pubitemid 44425731)
38. Ghadially R, Brown BE, Sequeira-Martin SM, et al. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest. 1995;95(5):2281-2290.
39. Ansel J, Perry P, Brown J, et al. Cytokine modulation of keratinocyte cytokines. J Invest Dermatol. 1990;94(6 Suppl):101S-107S. (Pubitemid 20213076)
40. Florin L, Maas-Szabowski N, Werner S, et al. Increased keratinocyte proliferation by JUN-dependent expression of PTN and SDF-1 in fibroblasts. J Cell Sci. 2005;118(Pt 9):1981-1989. (Pubitemid 40723841)
41. Finch PW, Rubin JS, Miki T, et al. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science .1989;245(4919):752-755. (Pubitemid 19214010)
42. Grossman RM, Krueger J, Yourish D, et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA. 1989;86(16):6367-6371. (Pubitemid 19210653)
43. Freedberg IM, Tomic-Canic M, Komine M, Blumenberg M. Keratins and the keratinocyte activation cycle. J Invest Dermatol. 2001;116(5):633-640. (Pubitemid 32467639)
44. Brauchle M, Angemeyer K, Hubner G, et al. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene. 1994;9:3199-3204. (Pubitemid 24338446)
45. Mansbridge J, Liu K, Patch R, et al. Three-dimensional fibroblast culture implant for the treatment of diabetic foot ulcers: Metabolic activity and therapeutic range. Tissue Eng. 1988;4(4):403-414.
46. Schütte H, Kula MR. Pilot- and process-scale techniques for cell disruption. Biotechnol Appl Biochm. 1990;12(6):599-620.
47. Fathke C, Wilson L, Shah K, et al. Wnt signaling induces epithelial differentiation during cutaneous wound healing. BMC Cell Biology. 2006;7:4.
48. Reya T, Clevers H. Wnt signaling in stem cells and cancer. Nature. 2005;434(7035):843-850. (Pubitemid 40558990)
49. Data on file, SkinMedica, 2009.
50. Bonin-Debs AL, Boche I, Gille H, Brinkmann U. Development of secreted proteins as biotherapeutic agents. Expert Opinion on Biological Therapy, 2004;4(4):551-558. (Pubitemid 38480554)
51. Stephanou A, Latchman DS. Molecular chaperone-Cytokine interactions at the trascriptional level. Molecular Chaperones and Cell Signalling. Edited by Brian Henderson and A. Graham Pockley, Cambridge University Press, 2005.
52. Gottscha TE, Bailey JE (eds). International Cosmetic Ingredient Dictionary and Handbook. Washington DC: Toiletry and Fragrance Association; 2008:1170-1174.
53. Ehrlich M, Rao J, Pabby A, et al. Improvement in the appearance of wrinkles with topical transforming growth factor beta(1) and lascorbic acid. Dermatol Surg. 2006;32:618-625 (Pubitemid 43742522)
54. Draelos ZD. Exploring the pitfalls in clinical cosmeceutical research. Cosmet Dermatol. 2007; 20:556-558. (Pubitemid 47573239)
55. Liu B, Earl HM, Baban D, et al. Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF. Biochem Biophys Res Commun. 1995;217(3):721-727. (Pubitemid 26019716)
56. FDA Communication about an Ongoing Safety Review of Regranex (becaplermin). Available at: http://www.fda.gov/cder/drug/ early-comm/ becaplermin.htm. Accessed June 2008.
57. Fitzpatrick RE, Rostan EF. Topical vitamin c for rejuvenation of photodamage: A double-blind study. Dermatol Surg. 2002;28(3):231-236. (Pubitemid 34259749)
58. Panin G, Strumia R, Ursini F. Alpha-tocopherol acetate in the bulk phase: Eight years of experience in skin treatment. Ann NY Acad Sci. 2004;1031:443-447. (Pubitemid 40361801)
59. Katiyar SK, Elmets CA. Green tea polyphenolic antioxidants and skin photoprotection. Int J Oncol. 2001;18(6):1307-1313.
60. Hoppe U, Bergemann J, Diembeck et al. Coenzyme Q10, a cutaneous antioxidant and energizer. Biofactors. 1999;9(2-4):371-378 (Pubitemid 29289021)
61. Obayashi K, Kurihara K, Okano Y, et al. L-Ergothioneine scavenges superoxide and singlet oxygen and suppresses TNF-alpha and MMP-1 expression in UV-irradiated human dermal fibroblasts. J Cosmet Sci. 2005;56(1):17-27. (Pubitemid 40545001)
62. Herrmann M, Grether-Beck S, Meyer I, et al. Blackberry leaf extract: A multifunctional anti-aging active. Int J Cosmet Sci. 2007;29(5):411.
63. Yang JG, Shen YH, Hong Y, et al. Stir-baked Fructus gardeniae (L.) extracts inhibit matrix metalloproteinases and alter cell morphology. J Ethnopharmacol, 2008;117(2):285-289.
64. Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988. (Pubitemid 351957385)
65. Krane SM. The importance of proline residues in the structure, stability and susceptibility to proteolytic degradation of collagens. Amino Acids. 2008;35(4):703-710.
66. Ertam I, Mutlu B, Unal I, et al. Efficiency of ellagic acid and arbutin in melasma: A randomized, prospective, open-label study. J Dermatol. 2008;35(9):570-574.
67. Bruce S. Cosmeceuticals for the attenuation of extrinsic and intrinsic dermal aging. J Drugs Dermatol. 2008;7(2 Suppl):S17-S22.
68. Murray JC, Burch JA, Streilein RD, et al. A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage cause by ultraviolet irradiation. J Am Acad Dermatol. 2008;59(3):418-425.
69. Park BS, Jang KA, Sung JH, et al. Adipose-derived stem cells and their secretory factors as a promising therapy for skin aging. Dermatol Surg. 2008;34(10):1323-1326.